BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35092107)

  • 1. The impact of the COVID-19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays.
    Slotman E; Schreuder K; Nijsten TEC; Wakkee M; Hollestein L; Mooyaart A; Siesling S; Louwman MWJ
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):680-687. PubMed ID: 35092107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
    Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
    JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
    Mokos M; Bašić-Jukić N
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults.
    Ferrante di Ruffano L; Dinnes J; Chuchu N; Bayliss SE; Takwoingi Y; Davenport C; Matin RN; O'Sullivan C; Roskell D; Deeks JJ; Williams HC;
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013187. PubMed ID: 30521689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study.
    Venables ZC; Nijsten T; Wong KF; Autier P; Broggio J; Deas A; Harwood CA; Hollestein LM; Langan SM; Morgan E; Proby CM; Rashbass J; Leigh IM
    Br J Dermatol; 2019 Sep; 181(3):474-482. PubMed ID: 30864158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989-2017.
    Tokez S; Wakkee M; Louwman M; Noels E; Nijsten T; Hollestein L
    JAMA Dermatol; 2020 Sep; 156(9):973-981. PubMed ID: 32609322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited impact of COVID-19-related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumour characteristics: a nationwide pathology registry analysis.
    Sangers TE; Wakkee M; Kramer-Noels EC; Nijsten T; Louwman MWJ; Jaspars EH; Hollestein LM
    Br J Dermatol; 2022 Aug; 187(2):196-202. PubMed ID: 35141890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma: A Population-Based Study in Olmsted County, Minnesota, 2000 to 2010.
    Muzic JG; Schmitt AR; Wright AC; Alniemi DT; Zubair AS; Olazagasti Lourido JM; Sosa Seda IM; Weaver AL; Baum CL
    Mayo Clin Proc; 2017 Jun; 92(6):890-898. PubMed ID: 28522111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
    Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
    JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma.
    Korhonen N; Ylitalo L; Luukkaala T; Itkonen J; Häihälä H; Jernman J; Snellman E; Palve J
    Arch Dermatol Res; 2021 Dec; 313(10):879-884. PubMed ID: 32772261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sun protection for preventing basal cell and squamous cell skin cancers.
    Sánchez G; Nova J; Rodriguez-Hernandez AE; Medina RD; Solorzano-Restrepo C; Gonzalez J; Olmos M; Godfrey K; Arevalo-Rodriguez I
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011161. PubMed ID: 27455163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference.
    Fargnoli MC; Antonetti P; Atzori L; Taddeucci P; Di Stefani A; Grandi V; Lospalluti L; Lacarrubba F; Vaccari S; Amerio P; Fabbrocini G; Rossi M; Campione E; Caposiena Caro RD; Moscarella E; Rongioletti F; Pellegrini C; Peris K; Discab
    Dermatology; 2023; 239(3):387-392. PubMed ID: 36754039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
    Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
    JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of disease caused by keratinocyte cancer has increased in The Netherlands since 1989.
    Hollestein LM; de Vries E; Aarts MJ; Schroten C; Nijsten TE
    J Am Acad Dermatol; 2014 Nov; 71(5):896-903. PubMed ID: 25190484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nationwide study of the incidence and trends of first and multiple basal cell carcinomas in the Netherlands and prediction of future incidence.
    Schreuder K; Hollestein L; Nijsten TEC; Wakkee M; Louwman MWJ
    Br J Dermatol; 2022 Mar; 186(3):476-484. PubMed ID: 34726263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
    Newlands C; Currie R; Memon A; Whitaker S; Woolford T
    J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's Disease, Melanoma, and Keratinocyte Carcinoma: A Population-Based Study.
    Lerman S; Amichai B; Weinstein G; Shalev V; Chodick G
    Neuroepidemiology; 2018; 50(3-4):168-173. PubMed ID: 29566384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusive development of a single type of keratinocyte skin cancer: evidence from an Australian population-based cohort study.
    Keim U; van der Pols JC; Williams GM; Green AC
    J Invest Dermatol; 2015 Mar; 135(3):728-733. PubMed ID: 25233075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of patients with basal cell carcinoma, squamous cell carcinoma, and squamous cell carcinoma in situ: A whole population study.
    Sharp K; Olafsdottir EJ; Sahni DR; Madsen S; Grant-Kels JM; Kristjansson A; Hoyt DW; Ungar JP; Frigerio A; Jonasson JG; Adalsteinsson JA
    J Am Acad Dermatol; 2024 Jan; 90(1):91-97. PubMed ID: 37758026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.